Document is current
Any future updates will be listed below
-
Authors
Fleischhauer, Moritz https://orcid.org/0009-0003-1419-3552
Berkenfeld, Kai
Stadermann, David
Velaga, Sitaram
Gonda, Igor
Langguth, Peter
Wachtel, Herbert
- License Information
-
More Information
Article History
Received: 18 June 2025
Accepted: 11 August 2025
First Online: 10 September 2025
Declarations
:
: Moritz Fleischhauer is carrying out PhD work supported by Boehringer Ingelheim. Kai Berkenfeld and Herbert Wachtel are full-time employees of Boehringer Ingelheim. Peter Langguth has nothing to disclose. Igor Gonda is co-founder and chairman of the board of Niconox. David Stadermann and Sitaram Velaga are executive officers of Kenox Pharmaceuticals.
: This analysis is an in vitro analysis and did not involve any human participants or animals. Therefore, the study did not require ethical approval.
